Search

everythinglearnresearchcommunity

for

Search:↓

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Increased PPARGC1α relates to hair thinning in common baldness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Check and treat low iron and vitamin D levels in people with hair loss.

Vegetable protein lowers cholesterol and protein deficiency can cause health issues.

Eating healthy, exercising, and changing behaviors are the best first steps to treat Polycystic Ovary Syndrome (PCOS).

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Melatonin and cortisol affect mink winter hair growth, but β-endorphin levels do not.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Skin aging reflects overall body aging and can indicate internal health conditions.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.